The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial Cancer

子宫内膜癌 淋巴血管侵犯 空格(标点符号) 细胞学 癌症 医学 肿瘤科 妇科 内科学 病理 转移 计算机科学 操作系统
作者
Cem Yagmur Ozdemir,Dağıstan Tolga Arıöz,Fatih Çelik,Nayif Çiçekli,Mariam Chkhikvadze,Filiz Bilir,Sezgin Yılmaz,Nefize Vatansever
出处
期刊:Discovery Medicine 卷期号:36 (181): 366-366
标识
DOI:10.24976/discov.med.202436181.34
摘要

Lymphovascular space invasion (LVSI) and cytology are both independent and strong prognostic factors in endometrial cancer. This study aims to highlight the impact of LVSI and cytology positivity on prognosis, in addition to molecular classification.A retrospective review was conducted on the records of 223 patients with endometrial cancer diagnosed between January 2011 and January 2021. The inclusion criteria stipulated that the patients were diagnosed with endometrial cancer by endometrial biopsy and were operated in the clinic. The exclusion criteria included sarcoma in the postoperative pathology report results or synchronous tumor. Staging was performed according to the Fédération internationale de gynécologie et d'obstétrique (FIGO) 2009 criteria. Cytology (using 50 cc saline) was obtained upon entry into the peritoneal cavity. In 20 patients, saline was not used due to the presence of ascites in the abdomen. The Kaplan-Meier method was employed to evaluate overall survival and progression-free survival. Survival rates were compared in terms of cytology and LVSI.After analyzing the postoperative pathology results, it was found that the mean tumor size was 4.03 ± 2.3 cm. The most common histological type was endometrioid carcinoma, with stage IA being the most common stage. Out of 223 patients with endometrial cancer, the overall survival rate was 82.4%, and the progression-free survival rate was 88.3%. For patients negative for LVSI, the progression-free survival rate was 93%, while for LVSI-positive patients, it was 77.3% (p < 0.001). Additionally, the progression-free survival rate for patients negative for cytology was 90.4%, whereas for cytology-positive patients, it was 77.1% (p < 0.05).In our study, we observed that LVSI positivity and cytology positivity also reduced the overall survival rate. We aimed to highlight that, in addition to molecular classification, cytology positivity and LVSI positivity are still highly significant and independent factors in prognosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雷欣儿完成签到 ,获得积分10
1秒前
2秒前
苹果酸奶完成签到 ,获得积分10
4秒前
Orange应助Snow采纳,获得10
4秒前
7秒前
文G发布了新的文献求助20
8秒前
甲木完成签到,获得积分10
12秒前
14秒前
15秒前
lulu完成签到,获得积分10
17秒前
努力向上的小刘完成签到 ,获得积分10
18秒前
封不迟发布了新的文献求助10
20秒前
耍酷的白山完成签到,获得积分10
25秒前
封不迟完成签到,获得积分10
25秒前
25秒前
GGGirafe完成签到,获得积分10
27秒前
31秒前
学术智子发布了新的文献求助10
31秒前
水瓶鱼完成签到,获得积分10
34秒前
34秒前
ln177发布了新的文献求助10
36秒前
情怀应助惊风采纳,获得10
38秒前
123发布了新的文献求助20
42秒前
44秒前
老迟到的远侵完成签到,获得积分10
44秒前
自然盼柳发布了新的文献求助10
49秒前
Owen应助聪慧远山采纳,获得10
49秒前
52秒前
fengbeing完成签到,获得积分10
54秒前
SciGPT应助常温采纳,获得10
54秒前
111发布了新的文献求助10
56秒前
Owen应助小乐采纳,获得30
56秒前
桐桐应助科研通管家采纳,获得10
1分钟前
Lucas应助科研通管家采纳,获得10
1分钟前
Orange应助科研通管家采纳,获得10
1分钟前
CodeCraft应助科研通管家采纳,获得10
1分钟前
田様应助科研通管家采纳,获得10
1分钟前
秋雪瑶应助科研通管家采纳,获得10
1分钟前
香蕉觅云应助科研通管家采纳,获得10
1分钟前
ssss应助科研通管家采纳,获得10
1分钟前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 1500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
india-NATO Dialogue: Addressing International Security and Regional Challenges 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2470065
求助须知:如何正确求助?哪些是违规求助? 2137143
关于积分的说明 5445356
捐赠科研通 1861390
什么是DOI,文献DOI怎么找? 925754
版权声明 562721
科研通“疑难数据库(出版商)”最低求助积分说明 495201